Giang is currently a PhD candidate researching substance use in young people, with a focus on e-cigarette vaping. Her PhD seeks to uncover factors influencing substance misuse in adolescents to provide evidence-based suggestions for public health interventions and substance-use control policies.

Myfanwy Graham is an NHMRC Postgraduate Scholar at Monash Addiction Research Centre, Monash University. Myfanwy is also a registered pharmacist, Schaeffer Fellow in Health Policy & Economics, at the University of Southern California, and Fulbright Scholar Alumna in cannabis public health policy. Her consultancy experience includes WHO, UNODC, and NASEM.

Robert has a background as a social worker in the AOD treatment system, as well as social policy research. With the ADF he advocates for evidence-based AOD policy at state and federal levels.

Dr Llew Mills is a postdoctoral researcher with the Discipline of Addiction Medicine, University of Sydney and South-Eastern Sydney Local Health District. His interests are cannabis dependence in a clinical and medicinal context, and in using routinely-collected clinical drug and alcohol data to improve drug and alcohol treatment.

Nicholas is an addiction medicine specialist and researcher with 35 years of experience in AOD sector. He has been involved in medicinal cannabis developments for over 10 years in Australia, and has led a number of clinical trials for the treatment of CUD.

Benjamin Trevitt is a fellow of the Australasian Faculty of Public Health Medicine of the Royal Australasian College of Physicians. He is currently training in addiction medicine and is also passionate about addiction medicine research.